Mammography

The U.S. Food and Drug Administration (FDA) cleared GE Healthcare’s Senographe Pristina with Self-Compression, the first 2-D digital mammography system that allows patients to increase or decrease the amount of compression applied to their own breast before the mammogram X-ray is taken.

Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how a personalized breast screening program can improve cancer detection for women with dense breasts at the 2017 AHRA annual meeting in Anaheim.

GE Healthcare has collaborated with Boca Raton Regional Hospital (Boca Raton, Fla.) to bring a more comfortable mammography system, Senographe Pristina to patients with next-generation 3-D digital mammography technology. It is the first installation of Senographe Pristina in the United States....

Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has approved High Definition Breast Tomosynthesis. This unique form of digital breast tomosynthesis (DBT) includes new algorithms designed to deliver a heightened level of sensitivity to breast cancer detection and...

March 31, 2017 — A recent analysis of newly added 2014 data to the National Cancer Institute SEER database by R. Edward Hendrick, Ph.D., shows that the breast cancer death rate has now fallen 38 percent since 1990.